Menu

Articles by : Tom Mirga, Editor at Large

Chicago Tribune’s 340B Article Grabs Senior U.S. Senator’s and Governor’s Attention (Updated)

Tom Mirga, Editor at Large Views
Chicago Tribune’s front page article yesterday about drug manufacturers’ denials of 340B pricing on medications dispensed by contract pharmacies got the attention of U.S. Senate Democratic Whip *** Durbin (Ill.) and Illinois Gov. J.B. Pritzker (D).

UPDATE Jan. 5, 2021 2:30 p.m. EST—Shortly after we published today’s issue, Pharmaceutical Research and Manufacturers of America (PhRMA) responded to our request for comment on the U.S. Health and Human Services (HHS) General Counsel’s Dec. 30 advisory opinion on

…
Read More »

Breaking News

BREAKING: HHS’s Top Lawyer Says Pharma’s 340B Contract Pharmacy Actions Are at Odds with the Law

Tom Mirga, Editor at Large Views
“Certain manufacturers’ newfound and unilateral refusal to sell [340B] drugs through contract pharmacies is at odds with the structure and intended operation of the [340B] statute,” HHS General Counsel Robert Charrow said in an advisory opinion late today. | Source:
…
Read More »

Providers Are Pleased, PhRMA Isn’t, With Becerra and State AGs’ 340B Letter to Azar

Tom Mirga, Editor at Large Views

Editor’s note—A cascade of breaking 340B news developments over the past seven days—Amgen’s orphan drug action, HRSA’s dispute resolution final rule, the hospital lawsuit against HHS, the state attorneys general letter to HHS and the new GAO report—forced us to

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live